Entero Healthcare Solutions IPO is a book erected issue of Rs 1,600.00 crores. The issue is the
combination of fresh issue of 00.79 crore shares adding up to Rs 1,000.00 crores and offer for trade of 00.48 crore shares adding up to Rs 600.00 crores.
Entero Healthcare results IPO opens for subscription on February 9, 2024 and closes on February 13, 2024. The allotment for the Entero Healthcare results IPO is anticipated to be perfected on Wednesday, February 14th, 2024. Entero Healthcare results IPO will list on BSE, NSE with conditional table date fixed as Friday, February 16, 2024.
Entero Healthcare results IPO price band is set at ₹ 1195 to ₹ 1258 per share. The minimal lot size for an operation is 11 Shares. The minimal quantum of investment needed by retail investors is ₹ 13,838. The minimal lot size investment for sNII is 15 lots( 165 shares), amounting to ₹ 207,570, and for bNII, it’s 73 lots( 803 shares), amounting to ₹.
ICICI Securities Limited, Dam Capital counsels Ltd( Formerly Idfc Securities Ltd), Jefferies India Private Limited, Jm Financial Limited and SBI Capital Markets Limited are the book running lead managers of the Entero Healthcare results IPO, while Link Intime India Private Ltd is the registrar for the issue.
Entero Healthcare Solutions IPO Details
| IPO Date | February 9, 2024 to February 13, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹1195 to ₹1258 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 12,718,600 shares (aggregating up to ₹1,600.00 Cr) |
| Fresh Issue | 7,949,125 shares (aggregating up to ₹1,000.00 Cr) |
| Offer for Sale | 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
| Employee Discount | Rs 119 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 16,066,886 |
| Share holding post issue | 24,016,011 |
About Entero Healthcare results Limited
Incorporated in 2018, Entero Healthcare results Limited is a distributor of healthcare products in India. The company’s technology- driven platform provides healthcare product distribution services to apothecaries, hospitals, and conventions throughout India.
During the financial times 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail guests, independently. also, they also served over 1,600, 2,500, and 3,400 sanitarium guests during the same period.
Entero Healthcare results has connections with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock- keeping units as of March 31, 2023.
The company has 73 storages in 37 metropolises across 19 countries and union homes, and its client base includes over 81,400 apothecaries and 3,400 hospitals in 495 sections as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a aggregate of 3014 people in various departments.
- Entero Healthcare results Limited Financial Information
- Entero Healthcare results Limited’s profit increased by 30.84% and profit after duty( PAT) rose by 62.28% between the fiscal time ending with March 31, 2023 and March 31, 2022.
| IPO Open Date | Friday, February 9, 2024 |
| IPO Close Date | Tuesday, February 13, 2024 |
| Basis of Allotment | Wednesday, February 14, 2024 |
| Initiation of Refunds | Thursday, February 15, 2024 |
| Credit of Shares to Demat | Thursday, February 15, 2024 |
| Listing Date | Friday, February 16, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 13, 2024 |
Objects of the Issue( Entero Healthcare results IPO objects)
The Company proposes to use the Net Proceeds from the Fresh Issue towards funding the following objects
- Prepayment/ repayment, in full or part, of certain borrowings profited of by the company and our Accessories.
- Funding the long term working capital conditions.
- Pursuing inorganic growth enterprise through accessions.
- General commercial purposes.